Accès ouvert
2026
article
OpenAlex
Ivana Dabaj, Thị Hoàng Trang Nguyễn, Emmanuelle Lagrue, Franklin Ducatez et autres
Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder caused by SMN1 gene variants, leading to the degeneration of anterior horn cells in the spinal cord. It is a disabling disease with varying severity. Nusinersen, the first approved in France, has …
fr
(code pays fourni par la source)
2025
article
OpenAlex
Aurélie Campeanu, Myriam Lamamri, J. M. Loeb, Jean-Michel Constantin et autres
fr
(code pays fourni par la source)
Accès ouvert
2025
preprint
OpenAlex
Laura Virtanen, Chiara D’Ercole, Lucile Saillard, Fiorella Carla Grandi et autres
Summary Duchenne muscular dystrophy (DMD) is a pediatric degenerative myopathy caused by the absence of functional dystrophin. As a result, DMD muscles exhibit compromised myofiber integrity and increased susceptibility to mechanical damage. In early disease stages, muscles undergo repeated cycles of degeneration …
fr, it
(code pays fourni par la source)
2025
article
OpenAlex
Fiorella Carla Grandi, Sonia Pezet, A. Arnould, Sonia Mazzucchi et autres
fr
(code pays fourni par la source)
Accès ouvert
2025
preprint
OpenAlex
Fiorella Carla Grandi, Sonia Pezet, A. Arnould, Sabrina Mazzucchi et autres
ABSTRACT Spinal muscular atrophy (SMA) is a rare developmental disorder affecting multiple tissues. Among the non-central nervous system tissues implicated in SMA is the skeletal system, including bone and cartilage. Low bone mineral density, increased numbers of fractures of the long bones …
fr, br
(code pays fourni par la source)
2024
article
OpenAlex
Fiorella Carla Grandi, Stéphanie Astord, Sonia Pezet, Elèna Gidaja et autres
Accès ouvert
2024
article
OpenAlex
Fiorella Carla Grandi, Stéphanie Astord, Sonia Pezet, Elèna Gidaja et autres
Spinal muscular atrophy (SMA) is a recessive developmental disorder caused by the genetic loss or mutation of the gene SMN1 (survival of motor neuron 1). SMA is characterized by neuromuscular symptoms and muscle weakness. Several years ago, SMA treatment underwent a radical …
fr
(code pays fourni par la source)
Accès ouvert
2024
article
OpenAlex
Delphine Sapaly, Flore Cheguillaume, Laure Weill, Zoé Clerc et autres
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder affecting motor neurons, with a typical lifespan of 3-5 years. Altered metabolism is a key feature of ALS that strongly influences prognosis, with an increase in whole body energy expenditure and changes in …
fr, de, us
(code pays fourni par la source)
2024
conference-paper
OpenAlex
Manon Beaujean, Amélie Briant, Nathalie Daniele, Daniel Stockholm et autres
International audience
Accès ouvert
2024
preprint
OpenAlex
Fiorella Carla Grandi, Stéphanie Astord, Elèna Gidaja, Sonia Pezet et autres
Spinal muscular atrophy (SMA) is a rare autosomal recessive developmental disorder caused by the genetic loss or mutation of the gene SMN1 (Survival of Spinal Motor Neuron 1). SMA is classically characterized by neuromuscular symptoms, including muscular atrophy, weakness of the proximal …
fr
(code pays fourni par la source)
Accès ouvert
2019
article
OpenAlex
Laura Muraine, Mona Bensalah, Jamila Dhiab, Gonzalo Córdova et autres
The adeno-associated virus (AAV) vector is an efficient tool for gene delivery in skeletal muscle. AAV-based therapies show promising results for treatment of various genetic disorders, including muscular dystrophy. These dystrophies represent a heterogeneous group of diseases affecting muscles and typically characterized …
fr
(code pays fourni par la source)
2019
conference-paper
OpenAlex
Jessy Etienne, Pierre Joanne, Alexandra Bayer, Cyril Catelain et autres
International audience
fr
(code pays fourni par la source)